Introduction: BRCA 1/2 genes play a critical role in the safeguarding of DNA integrity. Their mutation put women at increased risk of breast and ovarian cancers. Several line of evidence indicate that this genetic status may also be associated with ovarian dysfunction, in particular reduced ovarian reserve. In vitro maturation (IVM) of cumulo-oocyte complexes (COCs) retrieved at germinal vesicle stage, followed by vitrification of metaphase 2 oocytes, may represent an option for women seeking fertility preservation (FP), in whom ovarian stimulation is unfeasible. Since BRCA genes may play a role in the formation of synaptonemal complexes during meiosis, we hypothesized that their mutations might influence the oocyte maturation process. The present investigation aimed to compare IVM outcomes in breast cancer patients, carriers or not for BRCA 1/2 gene mutations.

